	Distinct NGS mutational landscape and prognostic implications in early-onset colorectal cancer: A dual-cohort analysis of TCGA PanCancer Atlas and MSK-IMPACT 50K. PLoS One Sertesen Çamöz E, Kaya OB, Erçelebi H, Karaçin C, Terzi YK, Y. PMID: 42821536 [PubMed - indexed for MEDLINE]
	Mailed faecal immunochemical test programmes and educational inequalities in colorectal cancer screening in Europe: a difference-in-differences analysis. Int J Epidemiol Jolidon V, Smit F, Delaruelle K, Wagner C, van der Linden BWA, Bracke P, Toma S, Burton-Jeangros C, Cullati S. PMID: 42821506 [PubMed - indexed for MEDLINE]
	The inflammation-epigenetics axis in gastric cancer: Helicobacter-driven field defects, immune escape, and therapeutic frontiers. Front Immunol Bai Y, Lu Z. PMID: 42819755 [PubMed - indexed for MEDLINE]
	Minimally Invasive Versus Open Total and Distal Gastrectomy After Chemotherapy for Gastric Cancer: A Nationwide Observational Study. Ann Gastroenterol Surg Hoshino N, Hirakawa S, Hisamori S, Tachimori H, Fujii Y, Kumagai K, Ueno H, Shirabe K, Obama K. PMID: 42819733 [PubMed - as supplied by publisher]
	Hypofractionated 44 Gy in 20 fractions versus conventional chemoradiation in cervical cancer: 2-year results of the randomized HYPOCx-iRex trial with an exploratory pooled analysis of a single-institute EMBRACE-II cohort. Brachytherapy Prasartseree T, Dankulchai P, Sittiwong W, Laolugsanalerd P, Seksunwiriya S, Wattanakul S, Rodwong T, Charoenwong P, Jirasuviboon W, Suriyanusorn N, Suppasedtanon A, Kositamongkol C, Phisalprapa P, Klopp AH. PMID: 42823295 [PubMed - as supplied by publisher]
	Clinical Outcomes of Ramucirumab Plus Taxane After Immune Checkpoint Inhibitor Therapy in HER2-negative Advanced Gastric Cancer. Anticancer Res Yamaguchi K, Kikuchi Y, Wakabayashi M, Kayashima M, Shiratori F, Suzuki T, Oshima Y, Yajima S, Matsuda T. PMID: 42823186 [PubMed - indexed for MEDLINE]
	Predictive Value of G8 Screening for Early Discontinuation of Gastric Cancer Adjuvant Chemotherapy. Anticancer Res Yasuda H, Shimamura M, Ichikawa T, Uratani R, Yoshiyama S, Ohi M, Yamamoto A, Imaoka H, Kitajima T, Shimura T, Kawamura M, Okita Y, Okugawa Y, Kobayashi M, Toiyama Y. PMID: 42823183 [PubMed - indexed for MEDLINE]
	Surgical Resection of Metachronous Liver Metastases in Non-colorectal Non-neuroendocrine Gastrointestinal Cancers: Systematic Review and Meta-analysis. Anticancer Res Cicolani A, Chiarini L, Goglia M, Giancola ML, Gallo G, Nigri G, Petrucciani N, Carrano FM, D'Angelo F, Aurello P. PMID: 42823176 [PubMed - indexed for MEDLINE]
	Preoperative Prognostic Nutritional Index Predicts Long-term Outcomes After Curative Gastrectomy for Gastric Cancer. Anticancer Res Kondo S, Mazaki J, Kaneko Y, Sakurai T, Yamada E, Iwasaki K, Oguma J, Kasahara K, Osakabe H, Kuwabara H, Kanazawa A, Koga H, Nagakawa Y. PMID: 42823166 [PubMed - indexed for MEDLINE]
	Post-hepatectomy-related DIC Predicts Poor Survival After Resection for Colorectal Liver Metastases. Anticancer Res Arizono M, Furukawa K, Tsunematsu M, Yamahata Y, Nakanishi H, Futagawa Y, Matsumoto M, Haruki K, Kobayashi H, Taniai T, Onda S, Iida K, Ikegami T. PMID: 42823165 [PubMed - indexed for MEDLINE]
	Baseline Gut Microbiota Composition Links Immune-nutritional Status to Clinical Outcomes in Non-small Cell Lung Cancer Treated With Atezolizumab-based Immunotherapy: A Multicenter Prospective Study. Anticancer Res Shoji F, Wakasu S, Kosai K, Kinoshita F, Matsubara T, Takamori S, Kozuma Y, Fujishita T, Toyokawa G, Tagawa T, Tanaka Y, Yamaguchi M, Okamoto T, Yamazaki K, Maehara Y. PMID: 42823161 [PubMed - indexed for MEDLINE]
	Real-world Outcomes of Trifluridine/Tipiracil With or Without Bevacizumab in Metastatic Colorectal Cancer: A Retrospective Cohort Study. Anticancer Res Kawazoe T, Ando K, Ryujin K, Nambara S, Tsuda Y, Nakanoko T, Oki E, Yoshizumi T. PMID: 42823158 [PubMed - indexed for MEDLINE]
	Gastric neuroendocrine tumours after prolonged proton pump inhibitor use. BMJ Case Rep Song J, Bien J, Hristova E, Mafnas C, Li D. PMID: 42823137 [PubMed - indexed for MEDLINE]
	Baseline characteristics of participants recruited into the COLO-COHORT study: a UK-wide resource for colorectal cancer prevention. BMJ Open Gastroenterol Dunneram Y, Hackney E, Manning S, Louca P, Stewart CJ, Taylor GS, Koo S, Young GR, Mitra S, Hampton JS, Dobson C, Neilson LJ, Addison C, Whelpton J, COLO-COHORT research team, Sharp L, Hull MA, Rees C. PMID: 42823104 [PubMed - indexed for MEDLINE]
	Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study. Radiother Oncol Hartfelt PB, Bisgaard ALH, Ejlsmark MW, Bahij R, Schytte T, Mahmood F, Pfeiffer P, Bernchou U. PMID: 42822782 [PubMed - as supplied by publisher]
	Crosstalk between visceral adipose tissue secretome and tumoral microenvironment in obesity-induced colorectal cancer. Biochim Biophys Acta Mol Basis Dis Stanciu DI, Hudi, Ginghin, G. PMID: 42822680 [PubMed - as supplied by publisher]
	Prevalence, Species Distribution, and Parasitic Burden of Cryptosporidium Infection in Cancer Patients: A Case-Control Study in Egypt. Acta Trop Okasha H, Ghallab MMI, Abdo SM, Mashaal AR, Gammal MME, El-Wakil ES. PMID: 42822657 [PubMed - as supplied by publisher]
	Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut microbiome on cancer development. Lancet Microbe Vogtmann E, Um CY, Zouiouich S, Absher D, Benamouzig R, Chan AT, Fu J, Garrett WS, Greiser KH, Havulinna AS, Huttenhower C, Hveem K, Kushi LH, Lahti L, Liou JM, Lituev A, Michaëlsson K, Milne RL, Næss M, Niiranen TJ, Olsen A, Patel AV, Rimm EB, Rowell S, Salomaa V, Sayols-Baixeras S, Segal E, Shrubsole MJ, Shu XO, Skarbinski J, Song M, Southey MC, Tjønneland A, Veiga P, Weersma RK, Wu MS, Zheng W, Zhernakova A, Shi J, Hong HG, Abnet CC, Sinha R. PMID: 42822491 [PubMed - as supplied by publisher]
	Lack of a systematic approach and unified standards in frailty assessment among patients with gastric cancer: a scoping review. Cancer Treat Res Commun Yang Z, Gu Y, Zhang J, Xing F, He C. PMID: 42822137 [PubMed - as supplied by publisher]
	Estimated cost, resource use, and health benefits of an increased use of next-generation multi-target stool DNA test for colorectal cancer screening from an integrated delivery network perspective. J Med Econ Dore M, Ebner DW, Fendrick AM, Estes C, Aranda G, Coleman A, Vahdat V, Karlitz JJ, Rua T, van Hees F, Limburg PJ. PMID: 42821825 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 245657

Page 1 of 12283



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy